Related Experiment Videos
Common pathways for primary hypertrophic and dilated cardiomyopathy.
E Kroumpouzou1, I P Gomatos, A Kataki
1Department of Cardiology, Hippokration Hospital, Athens Medical School, Greece.
Hybridoma and Hybridomics
|April 26, 2003
Summary
Cardiac myocytes overexpress oncogenes like c-fos, H-ras, and c-myc in hypertrophic and dilated cardiomyopathies. This suggests a shared growth pathway in these heart conditions and viral myocarditis.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Oncogene Research
Background:
- Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are distinct cardiac conditions.
- Viral myocarditis involves inflammation of the heart muscle.
- The role of specific gene expression in myocyte growth response is not fully understood.
Purpose of the Study:
- To investigate if hypertrophic cardiomyopathy, dilated cardiomyopathy, and viral myocarditis share a common mitogenic growth pathway.
- To determine the expression of c-fos, H-ras, and c-myc genes in cardiac biopsies from patients with these conditions.
Main Methods:
- Immunohistochemical analysis of c-fos, H-ras, and c-myc gene expression in myocardial biopsies.
- Comparison of gene expression in patients with HCM, DCM, myocarditis, and healthy controls.
- Correlation of staining results with patient demographic data.
Main Results:
- Overexpression of c-fos, H-ras, and c-myc proteins was observed in a significant proportion of HCM and DCM patients compared to controls (p = 0.006).
- Gene co-expression was significantly different in primary cardiomyopathy patients versus controls (p = 0.042).
- Myocarditis patients predominantly expressed only the c-fos protein.
Conclusions:
- Cardiac myocytes respond to biomechanical stress through oncogene expression, leading to hypertrophy.
- The findings support a shared oncogenic pathway in hypertrophic and dilated cardiomyopathies.
- Oncogene expression may contribute to the distinct morphological changes seen in HCM and DCM.